Methotrexate in blood, urine, and cerebrospinal fluid of children receiving high doses by infusion
- PMID: 1277503
Methotrexate in blood, urine, and cerebrospinal fluid of children receiving high doses by infusion
Abstract
Methotrexate was determined in plasma (31 patients), urine (eight patients), and cerebrospinal fluid (two patients) after high doses (35 to 150 mg/kg) by infusion, with citrovorum factor rescue. Concentrations in plasma were proportional to dose at 6, 24, 72 h after beginning treatment, but this trend was very minimal for samples obtained at 48 h. Clinical toxicity probably will not be serious if the methotrexate concentration in the serum is less than 4.5 X 10(-6) mol/liter at 48 h after the start of a 6-h infusion. In both of the two patients so examined, therapeutic concentrations appeared in cerebrospinal fluid after intravenous infusion of the drug. A kinetic enzymic method, radioassay, and radioimmunoassay all yielded similar results for drug concentrations.
Similar articles
-
A rapid and specific radioimmunoassay for methotrexate.Cancer Res. 1975 Jun;35(6):1407-10. Cancer Res. 1975. PMID: 1079473
-
Methotrexate in the plasma and cerebrospinal fluid of children treated with intermediate dose methotrexate.Acta Paediatr Scand. 1981 Sep;70(5):615-8. doi: 10.1111/j.1651-2227.1981.tb05755.x. Acta Paediatr Scand. 1981. PMID: 6976674
-
Methotrexate concentration levels in the cerebrospinal fluid during high-dose methotrexate infusions: an unreliable prediction.Pediatr Hematol Oncol. 1988;5(2):115-24. doi: 10.3109/08880018809031261. Pediatr Hematol Oncol. 1988. PMID: 3152957
-
Methotrexate. II. Use in pediatric chemotherapy.Am J Pediatr Hematol Oncol. 1984 Winter;6(4):397-413. Am J Pediatr Hematol Oncol. 1984. PMID: 6398630 Review.
-
Clinical pharmacokinetics of methotrexate in children.Clin Pharmacokinet. 1984 Jul-Aug;9(4):335-48. doi: 10.2165/00003088-198409040-00003. Clin Pharmacokinet. 1984. PMID: 6380871 Review.
Cited by
-
Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery.J Clin Invest. 1979 Aug;64(2):684-8. doi: 10.1172/JCI109509. J Clin Invest. 1979. PMID: 457877 Free PMC article.
-
Clinical pharmacokinetics of commonly used anticancer drugs.Clin Pharmacokinet. 1983 May-Jun;8(3):202-32. doi: 10.2165/00003088-198308030-00002. Clin Pharmacokinet. 1983. PMID: 6189661 Review.
-
Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma.JAMA Oncol. 2016 Feb;2(2):201-8. doi: 10.1001/jamaoncol.2015.4398. JAMA Oncol. 2016. PMID: 26583357 Free PMC article.
-
Effective therapy for Burkitt's lymphoma: high-dose cyclophosphamide + high-dose methotrexate with coordinated intrathecal therapy.Cancer Chemother Pharmacol. 1979;3(2):103-9. doi: 10.1007/BF00254980. Cancer Chemother Pharmacol. 1979. PMID: 583137 No abstract available.
-
The practical benefits of pharmacokinetics in the use of antineoplastic agents.Cancer Chemother Pharmacol. 1980;4(3):139-45. doi: 10.1007/BF00254011. Cancer Chemother Pharmacol. 1980. PMID: 6994913 Review. No abstract available.